Early Read-Time Performance of the OraQuick HCV Rapid Antibody Assay for the Exclusion of HCV Viremia [0.03%]
OraQuick HCV 快速抗体试验排除丙肝病毒感染的早期截断值评估
Jessie Torgersen,David Smookler,Rebecca Russell et al.
Jessie Torgersen et al.
Rapid point-of-care tests for hepatitis C virus (HCV) provide results in 20 min and allow linkage to care, particularly for difficult-to-reach populations. Prior work suggested an early reading time of the OraQuick (OQ) rapid HCV antibody l...
Risk Factors for Hepatitis C Virus Among the General Population in Sub-Saharan Africa-An Analysis of Systematic Review Data [0.03%]
撒哈拉以南非洲地区一般人群 hepatitis C 病毒感染的系统评价风险因素分析
Getahun Molla Kassa,Aaron G Lim,Melaku Tileku Tamiru et al.
Getahun Molla Kassa et al.
Understanding risk factors for hepatitis C virus (HCV) is critical for targeting screening and prevention. We systematically reviewed risk factors associated with HCV seroprevalence among the general population in sub-Saharan Africa (SSA). ...
Meta-Analysis
Journal of viral hepatitis. 2025 Oct;32(10):e70065. DOI:10.1111/jvh.70065 2025
Global Systematic Review of the Measurement of Stigma Associated With People Living With Hepatitis B or Hepatitis C Viruses [0.03%]
乙肝和丙肝患者的病耻感测量的全球系统评价
Freddy Green,Ruth Simmons,David Leeman et al.
Freddy Green et al.
Chronic hepatitis B and C affect over 300 million people globally. Despite treatment advances, stigma towards people living with hepatitis B/C (PLWHB/C) remains a barrier to care and impacts health outcomes. Addressing this stigma is key to...
HCV Screening Before Endoscopy in Hepatogastroenterology Outpatient Clinic: The Depist C Endo Study [0.03%]
肝胃肠门诊内镜前筛查丙型肝炎：Depist C Endo 研究
André-Jean Remy,Serge Bellon,Ryad Smadhi et al.
André-Jean Remy et al.
Systematic screening for hepatitis C virus (HCV) by serology once in a lifetime is recommended by the French Association for the Study of the Liver, but not by the French National Authority for Health. Screening focused on subjects aged ove...
Treatment Discontinuation and Adherence in Patients With Chronic Hepatitis B Infection Newly Initiating Nucleos(t)ide Analogues in Japan: A Retrospective Cohort Study [0.03%]
日本慢性乙型肝炎患者开始使用核苷（酸）类似物治疗后的治疗中止与依从性：一项回顾性队列研究
Shinya Kawamatsu,Kiran K Rai,Vera Gielen et al.
Shinya Kawamatsu et al.
Nucleos(t)ide analogue (NA) therapy is the current standard of care for chronic hepatitis B (CHB) virus infection but rarely achieves functional cure, necessitating long-term therapy, which often leads to nonadherence and increased treatmen...
Clinical Observational Study on HBV Reactivation After Direct-Acting Antiviral Therapy in HCV/HBV Coinfected Patients in Guizhou, China [0.03%]
中国贵州地区HCV和HBV合并感染患者直接抗病毒治疗后乙型肝炎病毒再激活的临床观察研究
Mei Wang,Yi Wang,Zhigang Yang et al.
Mei Wang et al.
The objective of this study is to analyse the prevalence and clinical characteristics of HCV/HBV coinfection in Guizhou, and evaluate the rate of HBV reactivation during and after anti-HCV treatment in a real-world study. This retrospective...
Observational Study
Journal of viral hepatitis. 2025 Sep;32(9):e70061. DOI:10.1111/jvh.70061 2025
Sarah Boudova,Neel S Iyer,Danielle M Tholey et al.
Sarah Boudova et al.
Pregnancy is a time of high patient motivation to initiate treatment for opioid use disorder (OUD). Hepatic drug metabolism can be altered by pregnancy and hepatitis C virus (HCV) infection. We aimed to examine the impact of HCV during preg...
Assessment of Hemophagocytic Lympho-Histiocytosis (HLH) in the Setting of Adult Acute Liver Failure [0.03%]
成人急性肝衰背景下评价噬血细胞淋巴组织细胞增生症(HLH)的诊断和预后价值
Ahmad Anouti,Hamza Dahshi,Jody Rule et al.
Ahmad Anouti et al.
Hemophagocytic lympho-histiocytosis (HLH) is a life-threatening disease, only occasionally presenting as acute liver failure (ALF) in adults. HLH is challenging to diagnose. We reviewed the ALF Study Group (ALFSG) registry for suspected HLH...
CHIME: Sofosbuvir/Velpatasvir (S/V) for the Treatment of HCV Infection Among Vulnerable Inner-City Residents [0.03%]
CHIME：索磷布韦/维帕他韦（Sovaракса/伏西瑞韦）治疗城市贫困地区居民的丙型肝炎病毒感染
Brian Conway,Shana Yi,Daivd Truong
Brian Conway
The combination of Sofosbuvir/Velpatasvir(S/V) is approved for the treatment of chronic HCV infection. In registrational trials, cure rates of 95% or more were achieved when administered as one pill per day for a period of 12 weeks, regardl...
Hepatitis E Virus Infection in Hyperbilirubinemia Patients Progressed to Liver Failure in 2003-2021, China [0.03%]
中国2003-2021年高胆红素血症患者感染戊型肝炎病毒进展为肝衰竭
Qiyu He,Jinling Dong,Liqin Huang et al.
Qiyu He et al.
Hepatitis E virus (HEV)-related liver failure is increasingly reported. Patients with hyperbilirubinemia usually indicate liver damage and may develop liver failure, but HEV infection in them is less studied. This study aimed to investigate...